Company creates alternative to price-gouged AIDS medication, sells it for less than $1 per pill

Good news for us, bad news for Martin Shkreli’s Turing Pharmaceutical.

 San Diego’s Imprimis Pharmaceuticals has created an alternative to Daraprim, a medication that commonly assists people who live with weakened immune systems (think people fighting AIDS and/or cancer) fight off toxoplasmosis and other infections. Historically, users paid roughly $13.50 per pill. Then Turing Pharma bought the rights to peddle the formula, and virtually overnight the pill was slapped with a $750 price tag — a devastating figure for many reliant on the medication. Fury erupted online not only concerning the price, but Shkreli’s “not my problem” tweets in the face of criticism.

Thankfully, the nightmare is over.

“It is indisputable that generic drug prices have soared recently,” Imprimis CEO Mark L. Baum states. “While we respect Turing’s right to charge patients and insurance companies whatever it believes is appropriate, there may be more cost-effective compounded options for medications, such as Daraprim.”

The company now offers a customization option for as low as $99 for a 100-count bottle.

Hats off to Imprimis for taking a stand.